CRISPR Therapeutics Market Sentiment

SPY779.88+0.24%QQQ743.60+0.00%BTC/USD83,263.00+0.19%DIA518.33+0.41%GLD379.50−0.57%TLT78.56+0.24%

Premium

CRISPR Therapeutics AG

CRSPNASDAQ

Trade with Public

$50.10

-1.45-2.81%

Last update: Oct 14, 5:53 AM

$50.60

-0.95-1.84%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

CRISPR Therapeutics Market Sentiment - Benzinga

CRISPR Therapeutics Market Sentiment

Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 22.1% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

—

Avg Consensus PT

$72

+42.7%

Highest Price Target

$120

+137.2%

Truist Securities

Lowest Price Target

$32

-36.8%

Morgan Stanley

Short Interest

22.1%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 31, 2026	Citizens	Silvan Turkcan—	+58.1%	$80 → $80	Maintained	Market Outperform
Aug 31, 2026	Needham	Gil Blum—	+62.1%	$82 → $82	Maintained	Buy
Aug 25, 2026	Citizens	Silvan Turkcan—	+58.1%	$80 → $80	Maintained	Market Outperform
Aug 4, 2026	Citigroup	Yigal Nochomovitz—	+73.9%	$82 → $88	Maintained	Buy
Jul 8, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+58.1%	$80 → $80	Maintained	Buy
Jul 6, 2026	Citizens	Silvan Turkcan—	+58.1%	$80 → $80	Maintained	Market Outperform
May 13, 2026	Bernstein	William Pickering—	+10.7%	$50 → $56	Maintained	Market Perform
May 6, 2026	Citigroup	Yigal Nochomovitz—	+62.1%	$80 → $82	Maintained	Buy
Mar 17, 2026	Piper Sandler	Edward Tenthoff—	+117.4%	$105 → $110	Maintained	Overweight
Feb 17, 2026	Chardan Capital	Geulah Livshits—	+50.2%	$74 → $76	Maintained	Buy
Feb 13, 2026	TD Cowen	Tyler Van Buren—	-11.1%	$40 → $45	Maintained	Hold
Feb 13, 2026	Evercore ISI Group	Liisa Bayko—	+46.2%	$62 → $74	Maintained	Outperform
Feb 13, 2026	Needham	Gil Blum—	+62.1%	$80 → $82	Maintained	Buy
Jan 30, 2026	Citizens	Silvan Turkcan—	+58.1%	$86 → $80	Maintained	Market Outperform
Dec 23, 2025	Needham	Gil Blum—	+58.1%	$80 → $80	Maintained	Buy
Dec 23, 2025	Citizens	Silvan Tuerkcan—	+70.0%	$86 → $86	Maintained	Market Outperform
Nov 26, 2025	Chardan Capital	Geulah Livshits—	+46.2%	$82 → $74	Maintained	Buy
Nov 12, 2025	Citigroup	Yigal Nochomovitz—	+52.2%	$87 → $77	Maintained	Buy
Nov 11, 2025	RBC Capital	Luca Issi—	-1.2%	$42 → $50	Maintained	Sector Perform
Nov 11, 2025	Baird	Jack Allen —	-13.0%	$52 → $44	Maintained	Neutral
Nov 10, 2025	Needham	Gil Blum—	+58.1%	$81 → $80	Maintained	Buy
Oct 17, 2025	B of A Securities	Geoff Meacham—	+83.8%	$78 → $93	Maintained	Buy
Oct 10, 2025	Needham	Gil Blum—	+60.1%	$81 → $81	Maintained	Buy
Sep 23, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+58.1%	$80 → $80	Maintained	Buy
Sep 18, 2025	JP Morgan	Brian Cheng—	+38.3%	$70	Initiate	Overweight